Decoding Autism Now
Biology of Autism — Advanced Testing
Decoding Autism Now · Advanced / Next-Step Testing

Advanced Testing — The Methylation / Catecholamine Channel

Gut channel confirmed active? This is the next step — a sixth upstream channel that identifies not just that a gut-derived marker is elevated, but which of two opposite mechanisms is driving it, and what that means for treatment.

Companion to Document 07 p-Cresol / PCS / PST-P Upstream vs. downstream
See framework disclaimer below
01 Why this channel is a next step, not a starting point

The five channels in Document 07 — Gut/LPS, Mitochondrial, MIA/Neuroinflammation, SST-14/Neuropeptide, and Environmental/Oxidative — are the right place to start. They're accessible, broadly validated, and answer the first question: which upstream systems are active in this child at all.

This page covers a sixth channel that sits one level deeper. It doesn't replace the Gut/LPS channel confirmation in Document 07 — it's what comes after. If zonulin, LBP, or gut dysbiosis markers have already confirmed active gut involvement, this channel identifies a specific, testable mechanism within that gut signal: a gut bacterial metabolite that directly interferes with catecholamine (dopamine and norepinephrine) production, and — critically — a way to tell whether the cause is upstream (too much substrate reaching the gut) or downstream (the body's own clearance capacity falling short). Those two causes call for different interventions, which is why this channel doesn't fold neatly into the existing five.

When to order this panel

After the Gut/LPS Channel confirmation threshold in Document 07, Section 04, has been met (zonulin + LBP + OAT dysbiosis markers, any two of three) — or sooner, if catecholamine-related symptoms (motivation, arousal, social engagement) are a specific concern alongside GI symptoms.

02 The mechanism — one gut metabolite, two opposite causes

p-Cresol is produced when gut bacteria ferment the amino acid tyrosine that escaped digestion — the same "hidden malnutrition" mechanism (pepsin failure, elevated gastric pH) documented elsewhere in this suite. The body converts most of it into p-cresyl sulfate (PCS) for excretion; free p-cresol is barely measurable in urine on its own; the detectable pool is almost entirely the converted form. Both forms reach the brain and directly inhibit the enzymes that produce dopamine and norepinephrine.

A single "elevated p-cresol" reading confirms this pathway is involved. It cannot tell you why — and why determines what you do next.

Upstream — substrate excess or bacterial overgrowth
Confirmed by

Free p-cresol:PCS ratio normal, with both metabolites elevated together. The gut is producing more p-cresol because more undigested tyrosine is reaching it — a digestion or microbiome-composition problem.

Protocol reorder

Points toward the existing Gut/LPS channel work already in Document 07 (gut repair, dietary peptide reduction) and pepsin/gastric-pH correction. See Document 08 for the IMIG-mediated hypothesis on this arm.

Downstream — impaired clearance capacity
Confirmed by

Free p-cresol:PCS ratio elevated. Digestion may be entirely normal — the bottleneck is the body's own capacity to conjugate and clear p-cresol, via the phenol sulfotransferase (PST-P) enzyme.

Protocol reorder

Gut-directed intervention alone will not resolve this arm — the gut was never the bottleneck. No established intervention exists yet for this branch; see Document 08 for the current open-question status.

The part a single number hides

Two children can show the identical "elevated p-cresol" result on a standard panel — one because of upstream substrate excess, one because of downstream clearance failure — and need opposite treatment. Only the ratio, paired with a direct enzyme assay, tells them apart.

03 The panel — what to order
Marker Sample What it resolves
Total p-cresol (screening) Urine Confirms gut-derived phenolic burden is elevated. What a standard urinary organic acids panel already reports.
Free p-cresol (quantified separately, not hydrolyzed) Urine or plasma Numerator for the discriminating ratio. Must be run as a distinct, non-hydrolyzed measurement — most standard panels report only the post-hydrolysis total.
p-Cresyl sulfate (PCS) Urine or plasma Denominator for the ratio; the dominant circulating and excreted form.
Free p-cresol : PCS ratio Derived Normal ratio, both elevated → upstream. Elevated ratio → downstream. The discriminating result.
Platelet PST-P activity Blood Direct test of clearance capacity — the enzyme responsible for p-cresol conjugation. Deficient in the majority of ASD patients in independent cohort studies.
Plasma DBH activity (or NE:DA ratio proxy) Blood Confirms whether the elevated burden is actually translating into impaired catecholamine synthesis — the clinically relevant endpoint.

Practical note

Free p-cresol and PCS are best requested as a paired, non-hydrolyzed panel from the same lab visit as any standard organic acids test — ask specifically for "free p-cresol, not hydrolyzed" alongside the total, since most labs report only the post-hydrolysis combined value by default.

04 Where to go next
i

Theoretical framework — not clinical guidance. The Autism Spectrum Disorder (ASD) Cascade is a systems-biology model integrating peer-reviewed findings across immunology, metabolism, gut biology, and neuroscience into a proposed mechanistic map. The free p-cresol:PCS ratio described here is a specific, testable prediction of that model — supported by independent human evidence for its individual components (p-cresol/PCS elevation, PST-P deficiency) but not yet validated as a combined diagnostic ratio in a prospective ASD cohort. It is intended as a research-informed framework — not a diagnostic tool or treatment protocol. All intervention decisions require qualified clinical oversight. For the evidence base, see the ASD Cascade Citations document in this suite.